Introducing Cochrane Evidence Synthesis Units

We have recently announced the launch of Cochrane's first-ever Evidence Synthesis Units. These collaborative, multi-topic research groups will play a crucial role in delivering trusted Cochrane evidence to address major global health challenges.

What are Evidence Synthesis Units?                           

These new Units are multi-topic research groups that will focus on developing high-quality, timely evidence syntheses in response to diverse stakeholder needs. The Units all have methodological expertise, local knowledge and access to a network of Cochrane experts, enabling them to produce high-quality Cochrane evidence that supports health systems, policy, and practice worldwide.

Global Reach and collaboration

The geographic spread of the new units reflects Cochrane’s commitment to producing evidence that helps to improve people’s health worldwide. Beyond generating high-quality evidence syntheses, the units will also adopt innovative methods, promote health equity and champion research integrity and strengthen or develop stakeholder partnerships to support Cochrane’s long-term sustainability,

Introducing our first Units:

We have announced five new Cochrane Evidence Synthesis Units, built on collaborations that will be led by senior Cochrane members from around the world:

• Cochrane Evidence Synthesis Unit Australia (Lead, Sally Green)

• Cochrane Evidence Synthesis Unit Iberoamerica (Lead, Eva Madrid)

• Cochrane Evidence Synthesis Unit India (Lead, Meenu Singh)

• Cochrane Evidence Synthesis Unit Germany (Lead, Nicole Skoetz)

• Cochrane Evidence Synthesis Unit Nigeria (Lead, Martin Meremikwu)

Each unit lead will be supported by a core team, that will deliver high-quality manuscripts, ensuring the prompt delivery of impactful Cochrane evidence, when and where it is needed.